A detailed history of Fifth Third Bancorp transactions in Mannkind Corp stock. As of the latest transaction made, Fifth Third Bancorp holds 1,000 shares of MNKD stock, worth $7,020. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 2,100 52.38%
Holding current value
$7,020
Previous $10,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$5.01 - $6.7 $5,511 - $7,370
-1,100 Reduced 52.38%
1,000 $6,000
Q2 2024

Jul 22, 2024

BUY
$4.05 - $5.43 $8,505 - $11,403
2,100 New
2,100 $10,000
Q3 2020

Nov 09, 2020

SELL
$1.56 - $2.08 $999 - $1,333
-641 Closed
0 $0
Q2 2020

Aug 05, 2020

SELL
$0.94 - $2.21 $376 - $884
-400 Reduced 38.42%
641 $1,000
Q1 2018

May 15, 2018

SELL
$2.28 - $3.8 $843 - $1,406
-370 Reduced 26.22%
1,041 $2,000
Q4 2017

Feb 14, 2018

BUY
$2.28 - $6.71 $820 - $2,415
360 Added 34.25%
1,411 $3,000
Q3 2017

Nov 14, 2017

BUY
$1.15 - $2.29 $11 - $22
10 Added 0.96%
1,051 $2,000
Q2 2017

Aug 11, 2017

BUY
N/A
1,041
1,041 $1,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.